Advancing Cancer Diagnostics

Cernostics, Inc. is developing technologies that will redefine the way cancer is diagnosed. Through a complex integration of quantitative pathology and advanced informatics supported by a robust electronic medical record management system, Cernostics is discovering new ways to find, see, and treat cancer.

Cernostics has a personalized healthcare approach to cancer diagnosis and treatment utilizing technology and intellectual property based on a systems approach to evaluating patient tissue samples including multiplexed florescence microscopy and imaging technology that holds great potential to produce better, safer and more cost-effective results.